<sup>131</sup>I辅以短期小剂量碳酸锂治疗Graves甲亢的研究

查金顺; 蒋艳; 徐源; 林钦秀; 黄春玲; 蒋婷吟; 查金顺; 蒋艳; 徐源; 林钦秀; 黄春玲; 蒋婷吟

doi:10.3760/cma.j.issn.1673-4114.2014.01.003

[1]

查金顺, 黄春玲, 蒋婷吟, 等. ¹³¹I治疗Graves甲状腺功能亢进症中碳酸锂的应用[J].国际放射医学核医学杂志, 2011, 35(2):93-99. doi: 10.3760/cma.j.issn.1673-4114.2011.02.007

[2]

查金顺.甲状腺超声体积测定计算甲状腺机能亢进症放射性碘治疗剂量[J].国外医学放射医学核医学分册, 2000, 24(5):216.

[3]

蒋宁一, 匡安仁, 谭建, 等. ¹³¹I治疗Graves甲亢专家共识(2010年)[J].中华核医学杂志, 2010, 30(5):346-351. doi: 10.3760/cma.j.issn.0253-9780.2010.05.019

[4]

Akin F, Yaylali GF, Bastemir M. The use of lithium carbonate in the preparation for definitive therapy in hyperthyroid patients[J]. Med Princ Pract, 2008, 17(2):167-170.

[5]

Bogazzi F, Bartalena L, Brogioni S, et al. Comparison of radioiodine with radioiodine plus lithium in the treatment of Graves′ hyperthyroidism[J]. J Clin Endocrinol Metab, 1999, 84(2):499-503.

[6]

Bal CS, Kumar A, Pandey RM. A randomized controlled trial to evaluate the adjuvant effect of lithium on radioiodine treatment of hyperthyroidism[J]. Thyroid, 2002, 12(5):399-405. doi: 10.1089/105072502760043486

[7]

Dunkelmann S, Künstner H, Nabavi E, et al. Lithium as an adjunct to radioiodine therapy in Graves′ disease for prolonging the intrathyroidal effective half-life of radioiodine. Useful or not?[J]. Nuklearmedizin, 2006, 45(5):213-218.

[8]

王长修.低摄¹³¹I率Graves病患者¹³¹I治疗时加用碳酸锂的临床价值[J].中国误诊学杂志, 2006, 6(1):32. doi: 10.3969/j.issn.1009-6647.2006.01.015

[9]

Bogazzi F, Bartalena L, Campomori A, et al. Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves′ disease[J]. J Clin Endocrinol Metab, 2002, 87(10):4490-4495. doi: 10.1210/jc.2002-020580

[10]

Mijnhout GS, Franken AA. Antithyroid drug regimens before and after ¹³¹I-therapy for hyperthyroidism:evidence-based?[J]. Neth J Med, 2008, 66(6):238-241.

[11]

Dunkelmann S, Kuenstner H, Nabavi E, et al. Change in the intrathyroidal kinetics of radioiodine under continued and discontinued antithyroid medication in Graves′ disease[J]. Eur J Nucl Med Mol Imaging, 2007, 34(2):228-236. doi: 10.1007/s00259-006-0234-z

[12]

Burch HB, Solomon L, Cooper DS, et al. The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after(131)I ablation for Graves′ disease[J]. J Clin Endocrinol Metab, 2001, 86(7):3016-3021.

[13]

Ng YW, Tiu SC, Choi KL, et al. Use of lithium in the treatment of thyrotoxicosis[J]. Hong Kong Med J, 2006, 12(4):254-259.

[14]

Hoogenberg K, Beentjes JA, Piers DA. Lithium as an adjunct to radioactive iodine in treatment-resistant Graves thyrotoxicosis[J]. Ann Intern Med, 1998, 129(8):670.

[15]

Barbaro D, Grosso M, Boni G, et al. Recombinant hurman TSH and ablation of post-surgical thyroid remnants in differentiated thyroid cancer:the effect of pre-treatment with furosemide and furosemide plus lithium[J]. Eur J Nucl Med Mol Imaging, 2010, 37(2):242-249. doi: 10.1007/s00259-009-1254-2

[16]

李舜, 林映芬, 张家云, 等.碳酸锂与丙基硫氧嘧啶对Graves病重型甲亢131碘疗效影响的比较[J].中国现代医学杂志, 2005, 15(19):2963-2965.

[17]

杨宾, 王伟, 翁孝刚, 等. ¹³¹I联合碳酸锂治疗Graves病疗效观察[J].中国误诊学杂志, 2006, 6(11):2111-2112. doi: 10.3969/j.issn.1009-6647.2006.11.061

[18]

赵辉, 张智勇, 徐晓红, 等. ¹³¹I合并小剂量碳酸锂治疗老年性甲状腺机能亢进的临床探讨[J].临床内科杂志, 2007, 24(10):716. doi: 10.3969/j.issn.1001-9057.2007.10.029

[19]

Mijnhout GS, Franken AA. Antithyroid drug regimens before and after ¹³¹I-therapy for hyperthyroidism:evidence-based?[J]. Neth J Med, 2008, 66(6):238-241.